Christopher Amos

Associate Director of Quantitative Science
Baylor College of Medicine
Houston, Texas, United States

Presentation(s):

• PB0924 - Venous thromboembolism risk in lung cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy

  Monday, June 26, 2023
  18:30 – 19:30 ET